Skip to content

Clinical trials

Completed Atherosclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: United States Clear all

327 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200110
20026
200312
200415
200511
200615
200720
200818
200925
201015
201115
201213
201310
201412
201510
201613
201720
20189
20199
20207
202111
20227
20233
20246
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed327

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)32
GlaxoSmithKline19
Boston Scientific Corporation10
Massachusetts General Hospital10
Emory University7
Johns Hopkins University7
Brigham and Women's Hospital6
Esperion Therapeutics, Inc.6
Novartis Pharmaceuticals6
University of Washington6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis327
Cardiovascular Diseases76
Coronary Artery Disease52
Coronary Disease25
Peripheral Arterial Disease25
Diabetes Mellitus24
Hypercholesterolemia24
Inflammation24
Hypertension23
Heart Diseases20

Trials

Showing 1 to 25 of 327. Each trial links to its page on Pharma Observatory.

227 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.